Gene transfer approaches to the lysosomal storage disorders.
The work summarized in this paper used animal and cell culture models systems to develop gene therapy approaches for the lysosomal storage disorders. The results have provided the scientific basis for a clinical trial of gene transfer to hematopoietic stem cells (HSC) in Gaucher disease which is now in progress. The clinical experiment is providing evidence of HSC transduction, competitive engraftment of genetically corrected HSC, expression of the GC transgene, and the suggestion of a clinical response. In this paper we will review the progress made in Gaucher disease and include how gene transfer might be studied in other lysosomal storage disorders.
Barranger
J A
JA
Human Genetics Department at the University of Pittsburgh, PA 15261, USA.
Rice
E O
EO
Swaney
W P
WP
D000818:Animals; D002986:Clinical Trials as Topic; D004195:Disease Models, Animal; D005776:Gaucher Disease / Q000628:therapy; D018014:Gene Transfer Techniques; D005962:Glucosylceramidase / Q000235:genetics; D006412:Hematopoietic Stem Cells / Q000502:physiology; D006801:Humans; D016464:Lysosomal Storage Diseases / Q000628:therapy*; D051379:Mice / Q000235:genetics
D005962:Glucosylceramidase